| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1686.6B | ¥1757.0B | -4.0% |
| Operating Income | ¥73.8B | ¥130.8B | -43.6% |
| Ordinary Income | ¥87.8B | ¥140.7B | -37.5% |
| Net Income | ¥72.8B | ¥108.7B | -33.0% |
| ROE | 4.9% | 7.4% | - |
FY2026 Q3 results show Takasago International Corporation recorded revenue of 168.7B yen (YoY -4.0%), operating income of 7.4B yen (YoY -43.6%), ordinary income of 8.8B yen (YoY -37.5%), and net income attributable to owners of parent of 7.3B yen (YoY -33.0%). The company faces significant profitability challenges with operating margin declining to 4.4% from 7.4% YoY, representing a 3.0 percentage point deterioration. Despite modest revenue decline, profit contraction is severe due to cost absorption issues. Non-operating income provided 2.1B yen support, primarily from dividend income of 0.6B yen, foreign exchange gains of 0.7B yen, and equity method income of 0.3B yen. Extraordinary gains of 1.0B yen from securities sales partially offset operating weakness. The company maintains full-year guidance of 225.0B yen revenue and 8.5B yen operating income, both representing YoY declines, indicating management expects continued headwinds.
Revenue declined 4.0% YoY to 168.7B yen, with all geographic segments except Europe experiencing weakness. Japan segment revenue decreased 7.7% to 67.9B yen from 73.5B yen, while Americas segment fell 19.0% to 43.1B yen from 53.1B yen, representing the steepest regional decline. Europe segment increased 2.0% to 33.5B yen from 32.8B yen, and Asia segment held relatively flat at 38.0B yen versus 37.8B yen prior year. The fragrance business, encompassing flavors, fragrances, aroma ingredients, and fine chemicals, comprises the core revenue base at 167.6B yen, with other real estate rental income contributing 1.1B yen.
Operating profit deteriorated sharply by 43.6% to 7.4B yen from 13.1B yen. Gross profit decreased to 54.6B yen (margin 32.4%) from an implied 59.4B yen (margin 33.8%), declining 8.1% YoY and indicating pricing pressure or product mix deterioration. SG&A expenses of 47.2B yen represent 28.0% of revenue, compared to an implied 26.3% ratio prior year, demonstrating inadequate cost control relative to revenue decline. The 1.7 percentage point increase in SG&A ratio directly contributed to operating margin compression. Japan segment operating income collapsed 95.4% to 0.2B yen from 4.3B yen, while Americas segment declined 48.6% to 1.4B yen from 2.8B yen. Asia segment proved resilient with operating income rising 20.8% to 4.7B yen from 3.9B yen, achieving the highest segment margin at 12.3%. Europe segment decreased 43.9% to 1.0B yen from 1.9B yen.
Ordinary income of 8.8B yen exceeded operating income by 1.4B yen due to net non-operating gains. Non-operating income totaled 2.1B yen, comprising dividend income of 0.6B yen, foreign exchange gains of 0.7B yen, and other income of 0.4B yen. Non-operating expenses of 0.7B yen consisted primarily of interest expense of 0.6B yen. The net non-operating contribution of 1.4B yen provided critical support, representing 18.9% of operating income. Profit before tax reached 9.5B yen after extraordinary gains of 1.0B yen from securities sales (non-recurring factor) and extraordinary losses of 0.3B yen. Income tax expense of 2.3B yen resulted in an effective tax rate of 23.6%. Net income attributable to owners of parent totaled 7.3B yen after minority interests of 0.5B yen.
The company exhibits a revenue down/profit down pattern with disproportionate profit decline. Operating leverage worked adversely as fixed cost absorption deteriorated amid revenue contraction, compounded by weak pricing power or unfavorable product mix shifts.
Japan segment generated revenue of 67.9B yen with operating income of 0.2B yen, yielding an operating margin of 0.3%, representing the core domestic business with severe profitability challenges. Americas segment recorded revenue of 43.1B yen with operating income of 1.4B yen (margin 3.4%), showing significant weakness particularly in revenue generation. Europe segment achieved revenue of 33.5B yen with operating income of 1.0B yen (margin 3.1%), maintaining moderate performance. Asia segment produced revenue of 38.0B yen with operating income of 4.7B yen (margin 12.3%), establishing itself as the highest-margin operation and the company's profit engine. Japan represents the largest segment by revenue share at 40.2% but contributes only 2.7% of total operating profit, indicating this core business faces fundamental profitability issues requiring urgent remediation. Asia segment, despite representing only 22.5% of revenue, contributes 63.5% of operating profit, highlighting geographic profit concentration risk. The 12.0 percentage point margin differential between Asia (12.3%) and Japan (0.3%) segments demonstrates material operational efficiency gaps across the business portfolio that warrant strategic review.
[Profitability] ROE of 4.9% reflects weak shareholder returns, substantially below the manufacturing industry median of 5.8%. Operating margin of 4.4% declined 3.0 percentage points from 7.4% YoY, falling significantly below the industry median of 8.9% and indicating competitive disadvantage in cost management. Net profit margin of 4.3% compared to industry median of 6.5% demonstrates below-average profitability. Gross profit margin of 32.4% decreased from 33.8% YoY, suggesting pricing pressure or unfavorable product mix shift. Basic EPS declined 36.1% to 69.26 yen from 108.43 yen, substantially underperforming revenue decline and reflecting severe earnings quality deterioration. [Cash Quality] Cash and deposits of 15.6B yen decreased 56.1% from 35.6B yen YoY, representing a critical liquidity deterioration. Short-term debt coverage stands at 0.51x, indicating cash reserves cover only half of short-term liabilities. Operating working capital turnover of 262 days (calculated from DSO 118 days, DIO 214 days, DPO 70 days implied) significantly exceeds industry median of 111.5 days, revealing substantial cash conversion inefficiency. [Investment Efficiency] Asset turnover of 0.63 slightly exceeds industry median of 0.56, indicating acceptable asset utilization relative to peers. Return on assets of 2.7% (annualized) falls below industry median of 3.4%. Return on invested capital of 3.0% (based on provided quality alert) significantly underperforms industry median of 6.0%, highlighting inadequate returns on deployed capital. [Financial Health] Equity ratio of 55.5% compares favorably to industry median of 63.8%, indicating moderate financial stability. Current ratio of 183.5% falls below industry median of 287%, suggesting relatively tighter short-term liquidity positioning. Debt-to-equity ratio of 0.80 demonstrates conservative leverage. Financial leverage of 1.80 sits above industry median of 1.53, indicating higher balance sheet gearing. Interest coverage of 12.5x provides adequate debt servicing capacity. Short-term liabilities represent 58.7% of total liabilities, triggering refinancing risk concerns given the depleted cash position.
Cash and deposits decreased 19.9B yen YoY to 15.6B yen from 35.6B yen, representing a severe 56.1% contraction that raises immediate liquidity concerns. This deterioration occurred despite modest revenue decline of only 4.0%, indicating significant cash consumption from non-operating activities. Working capital management shows material inefficiency with accounts receivable reaching 54.7B yen and inventories totaling 34.5B yen, both representing elevated levels relative to revenue scale. Days sales outstanding of 118 days substantially exceeds industry median of 85 days, indicating slower customer collection or lenient credit terms. Days inventory outstanding of 214 days dramatically exceeds industry median of 112 days, revealing inventory management challenges or slow-moving stock accumulation. Combined with days payable outstanding, the cash conversion cycle extends to 262 days compared to industry median of 111.5 days, demonstrating poor working capital efficiency that traps significant cash. Accounts payable of 22.0B yen provides some supplier financing, but the company has not optimized payables management given overall working capital strain. Short-term borrowings increased to 30.8B yen from 20.5B yen prior period, suggesting reliance on external financing to support operations amid cash decline. The cash coverage of short-term liabilities at 0.51x indicates insufficient liquid resources to meet near-term obligations, necessitating either improved cash generation or additional financing arrangements. Investment securities holdings of 25.3B yen provide potential liquidity buffer through asset monetization, evidenced by 1.0B yen securities sale gains in the period. Long-term loans of 21.7B yen remain relatively stable, indicating the company has not yet tapped long-term debt markets for liquidity support. The combination of depleted cash, extended working capital cycle, and elevated short-term debt creates refinancing risk that requires immediate management attention through aggressive working capital reduction and operational cash flow improvement.
Operating income of 7.4B yen versus ordinary income of 8.8B yen reflects net non-operating contribution of 1.4B yen, representing 18.9% incremental support from financial activities. Non-operating income totaled 2.1B yen, comprising dividend income of 0.6B yen from equity investments, foreign exchange gains of 0.7B yen benefiting from yen depreciation, and other non-operating income of 0.4B yen. Interest expense of 0.6B yen on borrowings represents the primary non-operating cost. The non-operating income of 2.1B yen represents 1.2% of revenue, indicating moderate but meaningful contribution from financial activities. Extraordinary gains of 1.0B yen from investment securities sales represent non-recurring items that artificially enhance net income, accounting for 13.7% of profit before tax and demonstrating reliance on one-time asset monetization to support reported earnings. Comprehensive income of 7.0B yen attributable to owners diverges from net income of 6.8B yen due to foreign currency translation adjustments of negative 1.2B yen, partially offset by unrealized gains on securities of 1.6B yen. The presence of 1.0B yen extraordinary gains raises earnings quality concerns as these items are non-sustainable. Operating cash flow information is not disclosed in quarterly results, preventing direct assessment of cash earnings quality, but the severe working capital deterioration (CCC of 262 days) and cash balance decline of 19.9B yen strongly suggest operating cash flow significantly underperforms reported net income. The divergence between profit generation and cash generation, combined with reliance on securities sales for reported earnings, indicates below-average earnings quality requiring improvement through operational execution rather than financial engineering.
Full-year guidance projects revenue of 225.0B yen (YoY -1.8%), operating income of 8.5B yen (YoY -44.6%), and ordinary income of 10.0B yen (YoY -34.7%). Q3 cumulative progress rates against these targets reach 75.0% for revenue (168.7B yen / 225.0B yen), 86.8% for operating income (7.4B yen / 8.5B yen), and 87.8% for ordinary income (8.8B yen / 8.8B yen). Operating and ordinary income already exceed normal Q3 progress rate of 75%, suggesting limited profit expansion in Q4 or risk of full-year guidance shortfall. The company revised guidance during the quarter as indicated by disclosure, reflecting deteriorating business conditions. Revenue progress of 75.0% aligns with seasonal expectations, but profit progress exceeding 85% with one quarter remaining indicates either front-loaded earnings, seasonal Q4 weakness expected, or conservative guidance. Forecasted EPS of 107.72 yen compares to current cumulative EPS of 69.26 yen, implying Q4 net income of approximately 3.7B yen, materially above Q3 quarterly average and requiring operational improvement not yet evidenced. Annual dividend forecast of 28.00 yen (post-split basis) with previous interim dividend of 80.00 yen (pre-split basis) creates continuity challenges in assessment, though the company clarifies the annual equivalent is 260 yen on a pre-split basis. The guidance reflects management expectation of second-half recovery, but Q3 results show continued weakness casting doubt on full-year achievement. Absent order backlog disclosure, revenue visibility remains limited to short-term demand trends which appear challenging based on current performance.
Annual dividend forecast stands at 28.00 yen on a post-split basis (equivalent to 260 yen pre-split basis given the 1-to-5 stock split effective October 1, 2025), with interim dividend of 80.00 yen paid on pre-split basis and expected year-end dividend of 160.00 yen also on pre-split basis. The calculated payout ratio of 358.2% based on cumulative nine-month net income of 7.3B yen indicates dividends significantly exceed earnings, raising immediate sustainability concerns. This extraordinarily high payout ratio demonstrates the dividend is not supported by current earnings generation and likely draws on retained earnings or relies on anticipated full-year earnings recovery. Given forecasted full-year net income of approximately 10.5B yen (based on EPS forecast of 107.72 yen and 97.5M shares outstanding), the annual dividend of 260 yen per share (pre-split basis) implies full-year payout ratio of approximately 241%, still materially excessive and unsustainable. The company has not adjusted dividend policy despite severe earnings decline, suggesting commitment to shareholder returns even amid profitability stress, which raises questions about capital allocation priorities. No share buyback activity is disclosed in the period. The total shareholder return consists solely of dividends at this unsustainable level. The maintenance of dividends at 260 yen despite operating income declining 44.6% YoY reflects either confidence in near-term recovery or unwillingness to signal distress through dividend reduction, but strains financial flexibility given depleted cash position and working capital pressures. The payout ratio requires significant reduction through either dividend cut or dramatic earnings recovery to achieve sustainability, and investors should monitor Q4 results and subsequent dividend policy announcements closely.
Geographic revenue concentration in weakening markets, particularly Japan (40.2% of revenue) showing 7.7% decline and Americas (25.5% of revenue) declining 19.0%, creates top-line vulnerability if these regions do not stabilize. The company lacks adequate diversification to offset regional downturns. Raw material cost volatility for fragrance and flavor inputs directly impacts gross margin, with current gross margin decline to 32.4% from 33.8% YoY already demonstrating pricing power inadequacy. Absence of effective price escalation mechanisms or long-term contracts exposes profitability to commodity price shocks. Working capital management dysfunction evidenced by 262-day cash conversion cycle creates severe cash flow risk, with current trajectory unsustainable absent aggressive inventory reduction and receivables collection acceleration. Extended CCC ties up significant operating capital that could otherwise support growth or debt reduction, and inventory obsolescence risk increases with prolonged holding periods.
[Industry Position] (Reference - Proprietary Analysis)
Takasago International Corporation's profitability metrics fall below manufacturing industry benchmarks across multiple dimensions. Operating margin of 4.4% substantially underperforms industry median of 8.9%, ranking in the lower quartile and indicating competitive disadvantage in operational efficiency. Net profit margin of 4.3% trails industry median of 6.5%, demonstrating below-average earnings conversion. ROE of 4.9% sits below industry median of 5.8%, reflecting inadequate shareholder value creation. Return on assets of 2.7% (annualized) underperforms industry median of 3.4%, while ROIC of 3.0% significantly lags industry median of 6.0%, highlighting poor capital deployment effectiveness.
Working capital efficiency shows material underperformance with receivables turnover of 118 days substantially exceeding industry median of 85 days, and inventory turnover of 214 days dramatically worse than industry median of 112 days. The combined cash conversion cycle of 262 days significantly exceeds industry median of 111.5 days, placing the company in the bottom quartile for working capital management. This operational inefficiency directly impairs cash generation relative to peers.
Financial health metrics present mixed positioning. Equity ratio of 55.5% falls moderately below industry median of 63.8%, indicating acceptable but not superior financial stability. Current ratio of 183.5% substantially trails industry median of 287%, suggesting relatively tighter liquidity positioning than peers despite appearing adequate in absolute terms. Financial leverage of 1.80 exceeds industry median of 1.53, indicating higher balance sheet gearing. Asset turnover of 0.63 slightly outpaces industry median of 0.56, representing a relative strength in asset utilization efficiency.
The company's revenue decline of 4.0% underperforms industry median revenue growth of 2.8%, indicating loss of market position or end-market weakness exceeding sector average. EPS decline of 36.1% dramatically underperforms industry median EPS growth of 9%, placing the company in severe earnings distress relative to manufacturing peers.
Overall positioning reflects a company facing significant operational challenges with below-average profitability, weak working capital management, and deteriorating competitive position. The company requires substantial operational improvement to achieve industry-average performance levels.
(Industry: Manufacturing, Comparison: FY2025-Q3, Source: Proprietary analysis)
Takasago International Corporation exhibits severe earnings quality deterioration with operating margin contracting 3.0 percentage points to 4.4%, placing profitability in the bottom quartile of manufacturing peers and indicating fundamental competitive challenges requiring urgent operational restructuring. The disproportionate profit decline of 43.6% versus modest revenue decline of 4.0% demonstrates inadequate cost structure flexibility and pricing power weakness that cannot be explained by temporary factors alone.
Working capital management dysfunction represents the most critical financial risk, with cash conversion cycle of 262 days dramatically exceeding industry median of 111.5 days and tying up substantial operating capital. The combination of 118-day receivables cycle and 214-day inventory cycle creates chronic cash consumption that depleted cash reserves by 56.1% YoY to only 15.6B yen. This working capital trap prevents the company from generating adequate operating cash flow despite reporting accounting profits, evidenced by cash decline far exceeding net income trends. Immediate aggressive action on inventory reduction and receivables acceleration is essential to restore cash generation capability.
Financial flexibility has deteriorated materially with cash coverage of short-term liabilities at only 0.51x and short-term debt representing 58.7% of total liabilities, creating refinancing risk in the near term. The unsustainable dividend payout ratio of 358.2% (calculated on nine-month basis) or approximately 241% on full-year forecast basis demonstrates capital allocation policy inconsistent with earnings reality. The company faces a choice between dividend reduction or continuing to draw down retained earnings and financial flexibility, with the former being the prudent course to preserve financial stability.
Geographic profit concentration in Asia segment (63.5% of operating profit from only 22.5% of revenue) creates earnings vulnerability, while the Japan core business operating at 0.3% margin represents a strategic liability requiring either restructuring or exit consideration. The company's reliance on 1.0B yen of non-recurring securities sale gains to support reported earnings, combined with 1.4B yen net non-operating income contribution, indicates core operations generate insufficient profitability and masks underlying operational weakness in reported results.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.